Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Rheumatology
•
Hematology
•
General Rheumatology
•
Infectious Disease
•
Gastroenterology
•
Vaccines
•
immunizations
•
Allergy & Immunology
•
Nephrology
•
Immunosuppression
•
Cardiology
•
Primary Care
What is your approach to RSV vaccination in immunocompromised patients?
Related Questions
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
Is it better to give dose 2 of the mRNA 2024-2025 Covid-19 vaccine at month 2 or month 6 after dose 1 in moderately immunocompromised patients?
Do you pursue coronary artery calcium scoring in patients with metabolic risk factors and autoimmune disease in order to guide decisions regarding GLP-1 medications?
Are there any concerns when combining apremilast with azathioprine?